Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2023-2029

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.

LPI (LP Information)' newest research report, the “Prostate Cancer Diagnostics Industry Forecast” looks at past sales and reviews total world Prostate Cancer Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Prostate Cancer Diagnostics sales for 2023 through 2029. With Prostate Cancer Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate Cancer Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Prostate Cancer Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prostate Cancer Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostate Cancer Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate Cancer Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate Cancer Diagnostics.

The global Prostate Cancer Diagnostics market size is projected to grow from US$ 13140 million in 2022 to US$ 22650 million in 2029; it is expected to grow at a CAGR of 8.1% from 2023 to 2029.

Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. Those key players got about 4% market shares. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
    Tumor Biomarker Tests
    Imaging
    Biopsy
    Other

Segmentation by application
    Age Below 55
    Age 55-75
    Age Above 75

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    OPKO
    Genomic Health
    Abbott
    Beckman Coulter
    Siemens Healthcare
    bioMeriux
    Roche
    MDx Health
    DiaSorin
    Myriad Genetics
    Ambry Genetics

List of Tables
    Table 1. Prostate Cancer Diagnostics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
    Table 2. Major Players of Tumor Biomarker Tests
    Table 3. Major Players of Imaging
    Table 4. Major Players of Biopsy
    Table 5. Major Players of Other
    Table 6. Prostate Cancer Diagnostics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
    Table 7. Global Prostate Cancer Diagnostics Market Size by Type (2018-2023) & ($ Millions)
    Table 8. Global Prostate Cancer Diagnostics Market Size Market Share by Type (2018-2023)
    Table 9. Prostate Cancer Diagnostics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
    Table 10. Global Prostate Cancer Diagnostics Market Size by Application (2018-2023) & ($ Millions)
    Table 11. Global Prostate Cancer Diagnostics Market Size Market Share by Application (2018-2023)
    Table 12. Global Prostate Cancer Diagnostics Revenue by Players (2018-2023) & ($ Millions)
    Table 13. Global Prostate Cancer Diagnostics Revenue Market Share by Player (2018-2023)
    Table 14. Prostate Cancer Diagnostics Key Players Head office and Products Offered
    Table 15. Prostate Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
    Table 16. New Products and Potential Entrants
    Table 17. Mergers & Acquisitions, Expansion
    Table 18. Global Prostate Cancer Diagnostics Market Size by Regions 2018-2023 & ($ Millions)
    Table 19. Global Prostate Cancer Diagnostics Market Size Market Share by Regions (2018-2023)
    Table 20. Global Prostate Cancer Diagnostics Revenue by Country/Region (2018-2023) & ($ millions)
    Table 21. Global Prostate Cancer Diagnostics Revenue Market Share by Country/Region (2018-2023)
    Table 22. Americas Prostate Cancer Diagnostics Market Size by Country (2018-2023) & ($ Millions)
    Table 23. Americas Prostate Cancer Diagnostics Market Size Market Share by Country (2018-2023)
    Table 24. Americas Prostate Cancer Diagnostics Market Size by Type (2018-2023) & ($ Millions)
    Table 25. Americas Prostate Cancer Diagnostics Market Size Market Share by Type (2018-2023)
    Table 26. Americas Prostate Cancer Diagnostics Market Size by Application (2018-2023) & ($ Millions)
    Table 27. Americas Prostate Cancer Diagnostics Market Size Market Share by Application (2018-2023)
    Table 28. APAC Prostate Cancer Diagnostics Market Size by Region (2018-2023) & ($ Millions)
    Table 29. APAC Prostate Cancer Diagnostics Market Size Market Share by Region (2018-2023)
    Table 30. APAC Prostate Cancer Diagnostics Market Size by Type (2018-2023) & ($ Millions)
    Table 31. APAC Prostate Cancer Diagnostics Market Size Market Share by Type (2018-2023)
    Table 32. APAC Prostate Cancer Diagnostics Market Size by Application (2018-2023) & ($ Millions)
    Table 33. APAC Prostate Cancer Diagnostics Market Size Market Share by Application (2018-2023)
    Table 34. Europe Prostate Cancer Diagnostics Market Size by Country (2018-2023) & ($ Millions)
    Table 35. Europe Prostate Cancer Diagnostics Market Size Market Share by Country (2018-2023)
    Table 36. Europe Prostate Cancer Diagnostics Market Size by Type (2018-2023) & ($ Millions)
    Table 37. Europe Prostate Cancer Diagnostics Market Size Market Share by Type (2018-2023)
    Table 38. Europe Prostate Cancer Diagnostics Market Size by Application (2018-2023) & ($ Millions)
    Table 39. Europe Prostate Cancer Diagnostics Market Size Market Share by Application (2018-2023)
    Table 40. Middle East & Africa Prostate Cancer Diagnostics Market Size by Region (2018-2023) & ($ Millions)
    Table 41. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Region (2018-2023)
    Table 42. Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2018-2023) & ($ Millions)
    Table 43. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Type (2018-2023)
    Table 44. Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2018-2023) & ($ Millions)
    Table 45. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Application (2018-2023)
    Table 46. Key Market Drivers & Growth Opportunities of Prostate Cancer Diagnostics
    Table 47. Key Market Challenges & Risks of Prostate Cancer Diagnostics
    Table 48. Key Industry Trends of Prostate Cancer Diagnostics
    Table 49. Global Prostate Cancer Diagnostics Market Size Forecast by Regions (2024-2029) & ($ Millions)
    Table 50. Global Prostate Cancer Diagnostics Market Size Market Share Forecast by Regions (2024-2029)
    Table 51. Global Prostate Cancer Diagnostics Market Size Forecast by Type (2024-2029) & ($ Millions)
    Table 52. Global Prostate Cancer Diagnostics Market Size Forecast by Application (2024-2029) & ($ Millions)
    Table 53. OPKO Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
    Table 54. OPKO Prostate Cancer Diagnostics Product Offered
    Table 55. OPKO Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 56. OPKO Main Business
    Table 57. OPKO Latest Developments
    Table 58. Genomic Health Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
    Table 59. Genomic Health Prostate Cancer Diagnostics Product Offered
    Table 60. Genomic Health Main Business
    Table 61. Genomic Health Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 62. Genomic Health Latest Developments
    Table 63. Abbott Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
    Table 64. Abbott Prostate Cancer Diagnostics Product Offered
    Table 65. Abbott Main Business
    Table 66. Abbott Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 67. Abbott Latest Developments
    Table 68. Beckman Coulter Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
    Table 69. Beckman Coulter Prostate Cancer Diagnostics Product Offered
    Table 70. Beckman Coulter Main Business
    Table 71. Beckman Coulter Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 72. Beckman Coulter Latest Developments
    Table 73. Siemens Healthcare Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
    Table 74. Siemens Healthcare Prostate Cancer Diagnostics Product Offered
    Table 75. Siemens Healthcare Main Business
    Table 76. Siemens Healthcare Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 77. Siemens Healthcare Latest Developments
    Table 78. bioMeriux Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
    Table 79. bioMeriux Prostate Cancer Diagnostics Product Offered
    Table 80. bioMeriux Main Business
    Table 81. bioMeriux Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 82. bioMeriux Latest Developments
    Table 83. Roche Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
    Table 84. Roche Prostate Cancer Diagnostics Product Offered
    Table 85. Roche Main Business
    Table 86. Roche Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 87. Roche Latest Developments
    Table 88. MDx Health Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
    Table 89. MDx Health Prostate Cancer Diagnostics Product Offered
    Table 90. MDx Health Main Business
    Table 91. MDx Health Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 92. MDx Health Latest Developments
    Table 93. DiaSorin Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
    Table 94. DiaSorin Prostate Cancer Diagnostics Product Offered
    Table 95. DiaSorin Main Business
    Table 96. DiaSorin Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 97. DiaSorin Latest Developments
    Table 98. Myriad Genetics Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
    Table 99. Myriad Genetics Prostate Cancer Diagnostics Product Offered
    Table 100. Myriad Genetics Main Business
    Table 101. Myriad Genetics Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 102. Myriad Genetics Latest Developments
    Table 103. Ambry Genetics Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
    Table 104. Ambry Genetics Prostate Cancer Diagnostics Product Offered
    Table 105. Ambry Genetics Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 106. Ambry Genetics Main Business
    Table 107. Ambry Genetics Latest Developments
List of Figures
    Figure 1. Prostate Cancer Diagnostics Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Prostate Cancer Diagnostics Market Size Growth Rate 2018-2029 ($ Millions)
    Figure 6. Prostate Cancer Diagnostics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Figure 7. Prostate Cancer Diagnostics Sales Market Share by Country/Region (2022)
    Figure 8. Prostate Cancer Diagnostics Sales Market Share by Country/Region (2018, 2022 & 2029)
    Figure 9. Global Prostate Cancer Diagnostics Market Size Market Share by Type in 2022
    Figure 10. Prostate Cancer Diagnostics in Age Below 55
    Figure 11. Global Prostate Cancer Diagnostics Market: Age Below 55 (2018-2023) & ($ Millions)
    Figure 12. Prostate Cancer Diagnostics in Age 55-75
    Figure 13. Global Prostate Cancer Diagnostics Market: Age 55-75 (2018-2023) & ($ Millions)
    Figure 14. Prostate Cancer Diagnostics in Age Above 75
    Figure 15. Global Prostate Cancer Diagnostics Market: Age Above 75 (2018-2023) & ($ Millions)
    Figure 16. Global Prostate Cancer Diagnostics Market Size Market Share by Application in 2022
    Figure 17. Global Prostate Cancer Diagnostics Revenue Market Share by Player in 2022
    Figure 18. Global Prostate Cancer Diagnostics Market Size Market Share by Regions (2018-2023)
    Figure 19. Americas Prostate Cancer Diagnostics Market Size 2018-2023 ($ Millions)
    Figure 20. APAC Prostate Cancer Diagnostics Market Size 2018-2023 ($ Millions)
    Figure 21. Europe Prostate Cancer Diagnostics Market Size 2018-2023 ($ Millions)
    Figure 22. Middle East & Africa Prostate Cancer Diagnostics Market Size 2018-2023 ($ Millions)
    Figure 23. Americas Prostate Cancer Diagnostics Value Market Share by Country in 2022
    Figure 24. United States Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 25. Canada Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 26. Mexico Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 27. Brazil Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 28. APAC Prostate Cancer Diagnostics Market Size Market Share by Region in 2022
    Figure 29. APAC Prostate Cancer Diagnostics Market Size Market Share by Type in 2022
    Figure 30. APAC Prostate Cancer Diagnostics Market Size Market Share by Application in 2022
    Figure 31. China Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 32. Japan Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 33. Korea Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 34. Southeast Asia Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 35. India Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 36. Australia Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 37. Europe Prostate Cancer Diagnostics Market Size Market Share by Country in 2022
    Figure 38. Europe Prostate Cancer Diagnostics Market Size Market Share by Type (2018-2023)
    Figure 39. Europe Prostate Cancer Diagnostics Market Size Market Share by Application (2018-2023)
    Figure 40. Germany Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 41. France Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 42. UK Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 43. Italy Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 44. Russia Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 45. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Region (2018-2023)
    Figure 46. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Type (2018-2023)
    Figure 47. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Application (2018-2023)
    Figure 48. Egypt Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 49. South Africa Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 50. Israel Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 51. Turkey Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 52. GCC Country Prostate Cancer Diagnostics Market Size Growth 2018-2023 ($ Millions)
    Figure 53. Americas Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 54. APAC Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 55. Europe Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 56. Middle East & Africa Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 57. United States Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 58. Canada Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 59. Mexico Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 60. Brazil Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 61. China Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 62. Japan Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 63. Korea Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 64. Southeast Asia Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 65. India Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 66. Australia Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 67. Germany Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 68. France Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 69. UK Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 70. Italy Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 71. Russia Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 72. Spain Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 73. Egypt Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 74. South Africa Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 75. Israel Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 76. Turkey Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 77. GCC Countries Prostate Cancer Diagnostics Market Size 2024-2029 ($ Millions)
    Figure 78. Global Prostate Cancer Diagnostics Market Size Market Share Forecast by Type (2024-2029)
    Figure 79. Global Prostate Cancer Diagnostics Market Size Market Share Forecast by Application (2024-2029)

OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape